Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants

Eva Halapi, Thomas Leitner, Marianne Jansson, Gabriella Scarlatti, Paola Orlandi, Anna Plebani, Luisa Romiti, Jan Albert, Hans Wigzell, Paolo Rossi

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: To evaluate sequence evolution in relation to different rates of disease progression in infants infected with HIV-1. Design: Variability in the gp120 V3 region was analysed in HIV-1-infected children with different clinical courses, slow progression (n = 2) versus progressive disease (n = 3). Methods: Cloning and sequencing of virus-derived DNA from uncultured peripheral blood mononuclear cells was performed at two to three timepoints from birth and up to the fifth year of life. Sequence variability was estimated by calculating the genetic distance and the proportion and ratio of synonymous and non-synonymous nucleotide substitutions over time. Results: Genetic distances were significantly shorter in children with fast progression to disease, a predominance of synonymous nucleotide substitutions also being detected at later timepoints. Conversely, a preferential accumulation of non-synonymous nucleotide substitutions was apparent in children with slow disease progression. Furthermore, a positive correlation between a decreased ratio of synonymous/non-synonymous nucleotide substitutions and the ability of children's sera to react with synthetic peptides representing the autologous virus sequence was determined. Conclusion: Data suggest that an antigenically more diverse virus population emerges in infected children with slower progression to disease as a result of a stronger immune pressure.

Original languageEnglish
Pages (from-to)1709-1717
Number of pages9
JournalAIDS (London, England)
Volume11
Issue number14
DOIs
Publication statusPublished - 1997

Fingerprint

HIV
Disease Progression
Nucleotides
HIV-1
Viruses
DNA Viruses
Organism Cloning
Blood Cells
Parturition
Pressure
Peptides
Serum
Population

Keywords

  • Disease progression
  • Genetic variability
  • gp120 V3 region
  • Paediatric HIV-1 infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants. / Halapi, Eva; Leitner, Thomas; Jansson, Marianne; Scarlatti, Gabriella; Orlandi, Paola; Plebani, Anna; Romiti, Luisa; Albert, Jan; Wigzell, Hans; Rossi, Paolo.

In: AIDS (London, England), Vol. 11, No. 14, 1997, p. 1709-1717.

Research output: Contribution to journalArticle

Halapi, Eva ; Leitner, Thomas ; Jansson, Marianne ; Scarlatti, Gabriella ; Orlandi, Paola ; Plebani, Anna ; Romiti, Luisa ; Albert, Jan ; Wigzell, Hans ; Rossi, Paolo. / Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants. In: AIDS (London, England). 1997 ; Vol. 11, No. 14. pp. 1709-1717.
@article{e031935c02e1450f86cf764927b4ce71,
title = "Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants",
abstract = "Objective: To evaluate sequence evolution in relation to different rates of disease progression in infants infected with HIV-1. Design: Variability in the gp120 V3 region was analysed in HIV-1-infected children with different clinical courses, slow progression (n = 2) versus progressive disease (n = 3). Methods: Cloning and sequencing of virus-derived DNA from uncultured peripheral blood mononuclear cells was performed at two to three timepoints from birth and up to the fifth year of life. Sequence variability was estimated by calculating the genetic distance and the proportion and ratio of synonymous and non-synonymous nucleotide substitutions over time. Results: Genetic distances were significantly shorter in children with fast progression to disease, a predominance of synonymous nucleotide substitutions also being detected at later timepoints. Conversely, a preferential accumulation of non-synonymous nucleotide substitutions was apparent in children with slow disease progression. Furthermore, a positive correlation between a decreased ratio of synonymous/non-synonymous nucleotide substitutions and the ability of children's sera to react with synthetic peptides representing the autologous virus sequence was determined. Conclusion: Data suggest that an antigenically more diverse virus population emerges in infected children with slower progression to disease as a result of a stronger immune pressure.",
keywords = "Disease progression, Genetic variability, gp120 V3 region, Paediatric HIV-1 infection",
author = "Eva Halapi and Thomas Leitner and Marianne Jansson and Gabriella Scarlatti and Paola Orlandi and Anna Plebani and Luisa Romiti and Jan Albert and Hans Wigzell and Paolo Rossi",
year = "1997",
doi = "10.1097/00002030-199714000-00007",
language = "English",
volume = "11",
pages = "1709--1717",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "14",

}

TY - JOUR

T1 - Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants

AU - Halapi, Eva

AU - Leitner, Thomas

AU - Jansson, Marianne

AU - Scarlatti, Gabriella

AU - Orlandi, Paola

AU - Plebani, Anna

AU - Romiti, Luisa

AU - Albert, Jan

AU - Wigzell, Hans

AU - Rossi, Paolo

PY - 1997

Y1 - 1997

N2 - Objective: To evaluate sequence evolution in relation to different rates of disease progression in infants infected with HIV-1. Design: Variability in the gp120 V3 region was analysed in HIV-1-infected children with different clinical courses, slow progression (n = 2) versus progressive disease (n = 3). Methods: Cloning and sequencing of virus-derived DNA from uncultured peripheral blood mononuclear cells was performed at two to three timepoints from birth and up to the fifth year of life. Sequence variability was estimated by calculating the genetic distance and the proportion and ratio of synonymous and non-synonymous nucleotide substitutions over time. Results: Genetic distances were significantly shorter in children with fast progression to disease, a predominance of synonymous nucleotide substitutions also being detected at later timepoints. Conversely, a preferential accumulation of non-synonymous nucleotide substitutions was apparent in children with slow disease progression. Furthermore, a positive correlation between a decreased ratio of synonymous/non-synonymous nucleotide substitutions and the ability of children's sera to react with synthetic peptides representing the autologous virus sequence was determined. Conclusion: Data suggest that an antigenically more diverse virus population emerges in infected children with slower progression to disease as a result of a stronger immune pressure.

AB - Objective: To evaluate sequence evolution in relation to different rates of disease progression in infants infected with HIV-1. Design: Variability in the gp120 V3 region was analysed in HIV-1-infected children with different clinical courses, slow progression (n = 2) versus progressive disease (n = 3). Methods: Cloning and sequencing of virus-derived DNA from uncultured peripheral blood mononuclear cells was performed at two to three timepoints from birth and up to the fifth year of life. Sequence variability was estimated by calculating the genetic distance and the proportion and ratio of synonymous and non-synonymous nucleotide substitutions over time. Results: Genetic distances were significantly shorter in children with fast progression to disease, a predominance of synonymous nucleotide substitutions also being detected at later timepoints. Conversely, a preferential accumulation of non-synonymous nucleotide substitutions was apparent in children with slow disease progression. Furthermore, a positive correlation between a decreased ratio of synonymous/non-synonymous nucleotide substitutions and the ability of children's sera to react with synthetic peptides representing the autologous virus sequence was determined. Conclusion: Data suggest that an antigenically more diverse virus population emerges in infected children with slower progression to disease as a result of a stronger immune pressure.

KW - Disease progression

KW - Genetic variability

KW - gp120 V3 region

KW - Paediatric HIV-1 infection

UR - http://www.scopus.com/inward/record.url?scp=9844229369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9844229369&partnerID=8YFLogxK

U2 - 10.1097/00002030-199714000-00007

DO - 10.1097/00002030-199714000-00007

M3 - Article

C2 - 9386805

AN - SCOPUS:9844229369

VL - 11

SP - 1709

EP - 1717

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 14

ER -